A mathematical model of human thymidine kinase 2 activity

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 3, 2011, Pages 203-209

  Radivoyevitch, T ^a   Munch Petersen, B ^b   Wang, L ^c   Eriksson, S ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ROSKILDE UNIVERSITY   (Denmark)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

mathematical model; Thymidine kinase 2

Indexed keywords

DEOXYCYTIDINE; DEOXYCYTIDINE TRIPHOSPHATE; MONOMER; THYMIDINE; THYMIDINE KINASE; THYMIDINE KINASE 2; THYMIDINE TRIPHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; ENZYME KINETICS; MATHEMATICAL MODEL; NEGATIVE FEEDBACK; PROTEIN PHOSPHORYLATION;

HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; THYMIDINE KINASE;

EID: 79956083458     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.563765     Document Type: Article

References (15)

1. Reichard, P. Interactions between deoxyribonucleotide and DNA synthesis. Annu. Rev. Biochem. 1988, 57, 349-374.
2. Chabner, B.; Longo, D.L. Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott Williams & Wilkins, Philadelphia, 2005.
3. De Clercq, E.; Neyts, J. Antiviral agents acting as DNA or RNA chain terminators. In Antiviral Strategies (Kräusslich, H.G.; Bartenschlager, R. Eds.), Springer, New York, 2008, pp. 54-84.
4. Marti, R.; Nishigaki, Y.; Vila, M.R.; Hirano, M. Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders. Clin. Chem. Lab. Med. 2003, 41, 845-851. (Pubitemid 37010174)
5. Rampazzo, C.; Miazzi, C.; Franzolin, E., Pontarin, G.; Ferraro, P.; Frangini, M.; Reichard, P.; Bianchi, V. Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances. Mutat. Res. 2010, 703, 2-10.
6. Hill, A.V. The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves. J. Physiology 1910, 40, 4-7.
7. Wang, L.; Munch-Petersen, B.; Herrstrom Sjoberg, A.; Hellman, U.; Bergman, T.; Jornvall, H.; Eriksson, S. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett 1999, 443, 170-174. (Pubitemid 29078626)
8. Munch-Petersen, B.; Cloos, L.; Tyrsted, G.; Eriksson, S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem. 1991, 266, 9032-9038. (Pubitemid 21906614)
9. Wang, L.; Saada, A.; Eriksson, S. Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy. J. Biol. Chem. 2003, 278, 6963-6968. (Pubitemid 36800690)
10. Barroso, J.F.; Carvalho, R.N.; Flatmark, T. Kinetic analysis and ligand-induced conformational changes in dimeric and tetrameric forms of human thymidine kinase 2. Biochemistry 2005, 44, 4886-4896. (Pubitemid 40396766)
11. Barroso, J.F.; Elholm, M.; Flatmark, T. Tight binding of deoxyribonucleotide triphosphates to human thymidine kinase 2 expressed in Escherichia coli. Purification and partial characterization of its dimeric and tetrameric forms. Biochemistry 2003, 42, 15158-15169. (Pubitemid 38031715)
12. Munch-Petersen, B.; Wang, L.; Radivoyevitch, T.; Eriksson, S. Mitochondrial TK2 is a monomer in the absence and presence of its substrates. Abstract presented at the 14th International Symposium on Purine and Pyrimidine Metabolism in Man, February 18-21, 2011.
13. Ihaka, R.; Gentleman, R. R:a language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996, 5, 299-314.
14. Bradshaw, P.C.; Samuels, D.C.A computational model ofmitochondrial deoxynucleotidemetabolism and DNA replication. Am. J. Physiol. Cell Physiol. 2005, 288, C989-C1002. (Pubitemid 40559375)
15. Radivoyevitch, T.; Loparo, K.A.; Jackson, R.C.; Sedwick, W.D. On systems and control approaches to therapeutic gain. BMC Cancer 2006, 6, 104.